Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 21, 2009 - Issue 7
251
Views
10
CrossRef citations to date
0
Altmetric
Research Article

A poly(vinyl alcohol) nanoparticle platform for kinetic studies of inhaled particles

, , , , , , , & show all
Pages 631-640 | Received 15 Apr 2008, Accepted 15 Jul 2008, Published online: 23 Mar 2009

References

  • Bagchi, P. 1973. Theory of stabilization of spherical colloidal particles by nonionic polymers. J. Colloid Interface Sci. 47:86–99.
  • Buttini, F., Soltani, A., Colombo, P., Marriott, C., and Jones, S.A. 2008. Multilayer PVA adsorption onto hydrophobic drug substrates to engineer drug-rich microparticles. Eur. J. Pharm. Sci. 33:20–28.
  • Cartier, R., Kaufner, L., Paulke, B.R., Wustneck, R., Pietschmann, S., Michel, R., Bruhn, H., and Pison, U. 2007. Latex nanoparticles for multimodal imaging and detection in vivo. Nanotech. 18:1–12.
  • Chan, V.S.W. 2006. Nanomedicine: An unresolved regulatory issue. Regul. Toxicol. Pharmacol. 46:218–224.
  • Dailey, L.A., Jekel, N., Fink, L., Gessler, T., Schmehl, T., Wittmar, M., Kissel, T., and Seeger, W. 2006. Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung. Toxicol. Applied Pharmacol. 215:100–108.
  • Derjaguin, B.V., and Landau, V. 1941. Theory of the stability of strongly charged lyophobic soils and the adhesion of strongly charged particles in solutions of electrolytes. Acta Physiochem. U.R.S.S. 14:633–651.
  • Elmas, B., Tuncel, M., Yalçın, G., S¸enel, S., and Tuncel, A. 2005. Synthesis of uniform, fluorescent poly(glycidyl methacrylate) based particles and their characterization by confocal laser scanning microscopy. Colloids and Surfaces A: Physicochem. Eng. Aspects 269:125–134.
  • Fessi, H., Puisieux, F., Devissaguet, J.P., Ammoury, N., and Benita, S. 1989. Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55:R1–R4.
  • Ficek, B.J., and Peppas, N.A. 1993. Novel preparation of poly(vinyl alcohol) microparticles without crosslinking agent for controlled drug delivery of proteins. J. Control. Rel. 27:259–264.
  • Forbes, B. 2000. Human airway epithelial cell lines for in vitro drug transport and metabolism studies. P.S.T.T. 3:18–27.
  • Forbes, B., and Ehrhardt, C. 2005. Human respiratory epithelial cell culture for drug delivery applications. Eur. J. Pharm. Biopharm. 60:193–205.
  • Geys, J., Coenegrachts, L., Vercammen, J., Engelborghs, Y., Nemmar, A., Nemery, B., and Hoet, P.H.M. 2006. In vitro study of the pulmonary translocation of NPs: A preliminary study. Toxicol. Letters 160:218–226.
  • Grainger, C., Greenwell, L.L., Lockley, D.J., Martin, G.P., and Forbes, B. 2006. Culture of Calu-3 cells at the air-liquid interface provides a representative model of the airway epithelial barrier. Pharm. Res. 23:1482–1490.
  • Grenha, A., Grainger, C., Dailey, L.A., Seijo, B., Martin, G.P., Remuñán-López, C., and Forbes, B. 2007. Chitosan nanoparticle-containing microspheres are compatible with respiratory epithelial cells in vitro. Eur. J. Pharm. Sci. 31:73–84.
  • Health and Safety Executive (eds.) (HSE: 2004) Health effects of particles produced for nanotechnologies. EH75/6 December 2004, Health and Safety Executive, Great Britain.
  • Hiraku, O., and Yoshiharu, M. 1999. Biodegradation and distribution of water-soluble chitosan in mice. Biomaterials 20:175–182.
  • Hitzman, C.J., Elmquist, W.F., and Wiedmann, T.S. 2006. Development of a respirable, sustained release microcarrier for 5-fluorouracil II: In vitro and in vivo optimization of lipid coated nanoparticles. J. Pharm. Sci. 95:1127–1143.
  • Huang, M., Ma, Z., Khor, E., and Lim, L.Y. 2002. Uptake of FITC-chitosan NPs by A549 cells. Pharm. Res. 19:1488–1494.
  • Hyon, S.H., Cha, W.I., Ikada, Y., Kita, M., Ogura, Y., and Honda, Y. 1994. Poly(vinyl alcohol) hydrogels as soft contact lens material. J. Biomater. Sci. Polym. Ed. 5:397–406.
  • Kim, S., Lim, Y.S., Solyesz, E.G., De Grand, A.M., Lee, J., and Nakayama, A. 2004. Near infrared flurorescent type II quantum dots for sentinel lymph node mapping. Nat. Biotechnol. 22:92–97.
  • Jani, P.U., Florence, A.T., and Maccarthy, D.E. 1992. Further histological evidence of the gastrointestinal absorption of polystyrene NPs in the rat. Int. J. Pharm. 84:245–252.
  • Jones, S.A., Martin, G.P., and Brown, M.B. 2005. High-pressure aerosol suspensions – A novel laser diffraction particle sizing system for hydrofluroalkane metered dose inhalers. Int. J. Pharm. 302:154–165.
  • Li, J.K., Wang, N., and Wu, X.S. 1998. Poly(vinyl alcohol) NPs prepared by freezing-thawing process for protein/peptide drug delivery. J. Control. Rel. 56:117–126.
  • Limbach, L.K., Wick, P., Manser, P., Grass, R.N., Bruinink, A., and Stark, W.J. 2007. Exposure of engineered nanoparticles to human lung epithelial cells: Influence of chemical composition and catalytic activity on oxidative stress. Environ. Sci. Technol. 41:4158–4163.
  • Mathiowitz, E. 1999. Encyclopedia of Controlled Drug Delivery. Vol. 1, pp. 607–608. New York: Wiley-Interscience.
  • Novoa, G.A.G., Heinamaki, J., Mirza, S., Antikainen, O., Colarte, A.I., Paz, A.S., and Yliruusi, J. 2005. Physical solid-state properties and dissolution of sustained release matrices of polyvinylacetate. Eur. J. Pharm. Biopharm. 59:343–350.
  • Oberdorster, G., Finklestein, J.N., Johnston, C., Gelein, R., Cox, C., and Baggs, R.M. 2000. Acute pulmonary effects of ultrafine particles in rats and mice. Res. Rep. Health. Eff. Inst. 96:5–74.
  • Oberdorster, G., Oberdorster, E., and Oberdorster, J. 2005. Nanotoxicology: An emerging discipline evolving from studies of ultrafine particles. Environ. Health Persp. 113:823–839.
  • Pashley, R.M. 1981. Hydration forces between mica surfaces in aqueous electrolyte solutions. J. Colloid Interface Science 83:531–546.
  • Reis, C.P., Neufeld, R.J., Ribeiro, A.J., and Veiga, F. 2006. Nanoencapsulation I. Methods for preparation of drug-loaded polymeric NPs. Nanomed. Nanotech. Biol. Med. 2:8–21.
  • Rowe, R.C., Sheskey, P.J., and Weller, P.J. 2003. Polyvinyl alcohol. In Handbook of Pharmaceutical Excipients, eds. Rowe R.C., Weller P.J., Sheskey P.J., pp. 491–492. Bath: Pharmaceutical Press.
  • RS/RAE (Royal Society and Royal Academy of Engineering) 2004. Nanoscience and nanotechnologies: Opportunities and uncertainties. Plymouth: Latimer Trend Ltd.
  • Sakagami, M. 2006. In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv. Drug Del. Rev. 58:1030–1060.
  • Teeguarden, J.G., Hinderliter, P.M., Orr, G., Thrall, B.D., and Pounds, J.G. 2007. Particokinetics in vitro: Dosimetry considerations for in vitro nanoparticle toxicology assessments. Toxicol. Sci. 95:300–312.
  • Thanoo, B.C., Sunny, M.C., and Jayakrishnan, A. 1993. Controlled release of oral drugs from cross-linked polyvinyl alcohol microspheres. J. Pharm. Pharmacol. 45:16–20.
  • USEPA (US Environmental Protection Agency) 2007. US Environmental Protection Agency Nanotechnology White Paper; EPA 100/B-07/001.
  • Verwey, E.J.W., and Overbeek, J.Th.G. 1948. Theory of stability of lyophilic colloids. Amsterdam: Elsevier.
  • Wang, F., Tan, W.B., Zhang, Y., Fan, X., and Wang, M. 2006. Luminescent nanomaterials for biological labeling. Nanotech. 17: R1–R13.
  • Weiss, B., Schaefer, U.F., Zapp, J., Lamprecht, A., Stallmach, A., and Lehr, C.M. 2006. Nanoparticle made of fluorescence-labeled poly(L-lactide-co-glycolide): Preparation, stability and biocompatibility. J. Nanosci. Nanotech. 6:3048–3056.
  • Wong, D., and Parasrampuria, J. 1996. Polyvinyl alcohol. In Analytical profiles of drug substances and excipients, ed. H.G. Brittain Vol. 24, pp. 401–403. London: Academic Press.
  • Worle-Knirsch, J.M., Pulskamp, K., and Krug, H.F. 2006. Oops they did it again! Carbon nanotubes hoax scientists in viability assays. Nanoletters 6:1261–1268.
  • Yaghoobain, N., DeMaio, L., Xie, J., Hamm-Alvarez, S., Peng, C.A.,Borok, Z., Crandall, E.D., and Kim, K.J. 2006 Nanoparticles can injure and translocate across alveolar epithelial cell monolayers. F.A.S.E.B. 20:A1439.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.